Schatzman Randall C 4
4 · Bolt Biotherapeutics, Inc. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-04+654,000→ 235,000 totalExercise: $1.27Exp: 2034-03-03→ Common Stock (654,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.